Secuenciación en cáncer de mama avanzado HER2+ - page 48

Cross-over 45% de pacientes

Wildiers H, SABCS 2015

THERESA: OS

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,38,39,40,41,42,43,44,45,46,47 49,50,51,52,53,54,55,56,57,58,...60